SABCS 2024 | Reducing disparities in heart failure risk from trastuzumab in breast cancer
Karissa Britten
• 12 Dec 2024
Karissa Britten, MD, University of California, Los Angeles, CA, emphasizes the need for further studies to better understand the underlying mechanisms of the socioeconomic disparities in long-term heart failure risk of trastuzumab in early-stage breast cancer and implement evidence-based strategies to reduce this gap in the future. This interview took place at the 2024 San Antonio Breast Cancer Symposium (SABCS) congress in San Antonio, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
